Medtronic (NYSE:MDT) today touted five-year data for its In.Pact Admiral drug-coated balloon, highlighting the durability and efficacy of its device in people with peripheral artery disease in the superficial femoral and popliteal arteries.
The company presented five-year results from its pivotal In.Pact SFA trial at the 2018 Vascular Interventional Advances conference.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic touts five-year data for In.Pact Admiral drug-coated balloon appeared first on MassDevice.
from MassDevice https://ift.tt/2yVXuD7
Cap comentari:
Publica un comentari a l'entrada